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Objective: Osteoarthritis (OA) leads to pain and loss of function in affected joints. Gait disturbance results
from these symptoms of OA, and gait analysis can be important to evaluate the progression of OA. The
purpose of this study was to analyze gait pattern in a rodent model of OA and to assess the effects of
intra-articular injection of hyaluronan (IAI-HA) by gait analysis, along with histological evaluation.
Design: OA was induced by destabilization of the medial meniscus (DMM) of C57BL/6 mice. IAI-HA
started 3 weeks after DMM surgery. Mice were allocated to three groups and were given either 800-
kDa HA (800-HA), 6000-kDa HA (6000-HA) or saline. We compared these three groups with a sham
group by gait analysis using CatWalk. Histological evaluation was performed to assess articular carti-
lage changes in the knee joints.
Results: Mice injected with 800-HA or 6000-HA showed gait patterns similar to that of the sham mice,
while the saline-injected group showed gait disturbances 12 and 16 weeks after DMM surgery. Histo-
logical changes in articular cartilage were similar among the 800-HA, 6000-HA and saline-treated
groups, demonstrating OA progression throughout the experimental time points. Positive gait-related
effects of IAI-HA might occur by its pain relieving effect and/or by preventing contracture.
Conclusion: IAI-HA prevented gait disturbances in the DMM model, but did not prevent histological
changes associated with OA progression.
 2014 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.Introduction
Osteoarthritis (OA) leads to pain and loss of function in affected
joints and causes limitations in patients’ activity and diminishes
quality of life1. Pharmacological interventions are still insufﬁcient
to modify the progression of OA2.
To examine the efﬁcacy of interventions, a variety of animal
models have been developed. They are useful in histological eval-
uation but also allow us to study the behavioral changes. For thatT. Sasho, Department of Or-
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lf of Osteoarthritis Research Societpurpose, several behavioral assessments have been performed and
reviewed in previous literature3. Among them, gait analysis on
animal models may provide insights into the underlying OA pro-
gression and effects of interventions because gait is one of the
important activities of daily living impaired by OA4.
Recently, CatWalk (Noldus Information Technology, Wage-
ningen, The Netherlands) has been reported as a useful device for
gait analysis of rodent models5. But comprehensive gait analysis
against the widely used surgically induced OA model, destabiliza-
tion of the medial meniscus (DMM) model, has not been fully
performed yet.
Intra-articular injection of hyaluronan (IAI-HA) is widely used
and has clinically proven pain relieving effects and functional im-
provements2. In this study, using the DMM model, the efﬁcacies of
two different molecular-weight HAs were assessed by CatWalk
along with histology of the knee joint.
We hypothesized that gait parameters would change as OA
progresses, and that IAI-HA will have an effect on these changes in
gait parameters in the DMM model.y International.
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Animals
C57BL/6 mice (9 weeks old, male, n ¼ 60) were used. All pro-
tocols for animal procedures were approved by the Ethics Com-
mittee of Chiba University after the National Institutes of Health
Guidelines for the Care and Use of Laboratory Animals (1996
version).
Induction of OA
Micewere anesthetized by intraperitoneal injection of ketamine
(0.1 mg/g) and xylazine (0.01 mg/g). DMM surgery was performed
as previously described6. In this model, transection of meniscotibial
ligament leads to instability of the medial meniscus, which re-
sembles the slowly progressing OA.
Experimental design
DMM was performed on the left knee joints of 45 mice. Fifteen
mice underwent sham surgery on the left knee joint where only a
skin incision and medial capsulotomy with luxation of the patella
were performed. IAI was started 3 weeks after the DMM. The 45
mice with DMM were allocated equally to three groups, and were
given IAI into their left knees: (1) single weekly 800-HA (800-kDa,
Artz, Seikagaku Corp., Tokyo, Japan) injection for 5 weeks, (2)
single weekly 6000-HA (6000-kDa, Synvisc, Sanoﬁ Biosurgery,
Cambridge, MA) injection for 3 weeks, or (3) single weekly saline
injection for 5 weeks.
Gait analysis using CatWalkwas performed before the surgery
to obtain baseline data, and 3, 8, 12, 16 weeks after the surgery.
After the gait analysis, mice (n ¼ 5) were sacriﬁced at 8, 12, and 16
weeks from each group. Left knees were dissected and processed
for histological evaluation.
IAI
For IAI, mice were anesthetized by the same method as DMM
surgery and a small skin incision was made to identify the patellar
tendon. With a 30G needle, injection was performed through the
patellar tendon to ensure that HA or saline was injected into the
joint securely. Also, a handmade styrene foam stopper was pre-
pared and secured around the needle, so that the needle could only
be inserted 3 mm, avoiding damage to the articular cartilage. The
dose of each injection was 20 ml of 1% HA or 0.9% saline.
Gait analysis by CatWalk
In CatWalk (Noldus Information Technology, Wageningen,
Netherlands) system, mice are placed on a glass plate walkway and
allowed to walk freely. Fluorescent light is emitted inside the glass
plate and completely internally reﬂected. When the paws contact
the glass plate, light is reﬂected downward and recognized as a
bright image of the paw prints. These paw prints are captured by
the video camera set beneath the walkway and were analyzed by
software (CatWalk XT version 9) that generated the static gait
parameters such as contact area and paw pressure, and the dy-
namic gait parameters related to duration of the step. The software
automatically presents a total of 21 gait parameters.
Ten walks for each mouse were recorded. Three uninterrupted
walks were selected out of 10 recorded walks. Selection was done
by two observers (YM and YA) blinded to treatment. Gait analysis
was conducted on ﬁve mice for each group, thus a total of 15 walks
for each group were selected and analyzed at each time point. Toconsider individual differences between mice, the ratios of the
affected hind limb to the contralateral hind limb (left/right ratio) of
all 21 gait parameters were evaluated, and compared among
groups. Mean  95% conﬁdence interval of the ratios were
expressed.
Histological evaluation
After the gait analysis, all mice (n¼ 5 for each group at each time
point) were deeply anesthetized with intraperitoneal injection of
ketamine (0.2 mg/g) and xylazine (0.02 mg/g), then perfused with
4% paraformaldehyde. The knee joints were dissected free of
muscle and decalciﬁed in 20% ethylenediaminetetraacetic acid for
21 days, then knee joints were embedded in parafﬁn blocks. Sec-
tions of 4 mm thickness were made in coronal plane, at approxi-
mately 50 mm intervals throughout the whole knee joint. Slides
were stained by Safranin-O and Fast-Green.
The articular cartilage was assessed using the Osteoarthritis
Research Society International (OARSI) histological scoring system7.
Four quadrants of the joint; medial femoral condyle (MFC), lateral
femoral condyle (LFC), medial tibial plateau (MTP), and lateral tibial
plateau (LTP) were scored separately. For each quadrant, 10 slices
that sample the entire joint were scored and each quadrant score
was summed. The average scores of each group (n ¼ 5) were
compared among groups at each time point. Scoringwas performed
blindly by two authors (YM and HH). We also compared the scores
of the lateral compartment (LTP, LFC) and the medial compartment
(MTP,MFC) in each group at each time point, to see if OAprogression
or effect of intervention differs in two compartments.
Statistical analysis
Statistical analysis was performed using repeated measures
analysis of variance (ANOVA) followed by Bonferroni corrections to
compare longitudinal changes in each gait parameter within each
group. Non-repeated measures ANOVA followed by Studente
NewmaneKeuls test was used to compare each gait parameter
among groups. To compare histological scores among groups,
KruskaleWallis tests followed by SteeleDwass tests were used.
ManneWhitney’s U tests were used to compare the histological
scores of the medial and the lateral compartment. A P-value less
than 0.05 was considered statistically signiﬁcant.
Results
Gait analysis by CatWalk
In the saline-treated group, no signiﬁcant changes were seen in
the left/right ratio of any gait parameter through 8 weeks, but
signiﬁcantly shorter stance phase, single stance phase, duty cycle
(percentage of stance phase during the step cycle), and swing
speed, and a signiﬁcantly longer duration of swing phase were
observed at 12 and 16 weeks compared with the baseline data (0
week). In contrast, the 800-HA and 6000-HA groups showed a gait
pattern similar to that of the sham group, in which the ratio of gait
parameters did not change during the entire period. Gait parame-
ters that changed longitudinally in the saline-treated group were
signiﬁcantly different compared to the other groups at 12 and 16
weeks (Fig. 1). There were no statistical differences among sham,
800-HA or 6000-HA groups at any time period.
Histological evaluation
Histological changes were not apparent in the sham group,
whereas the saline-treated group demonstrated OA progression
Fig. 1. Longitudinal changes of gait parameters compared among groups. Values presented are mean  95% conﬁdence interval of the left (DMM applied knee)/right (contralateral
knee) ratio (%). In the saline-treated group, signiﬁcant differences were seen compared with the baseline (0 week) in: (A) Stance phase. 0 week; 96.3  6.4% vs 12 weeks; 85.6  6.4%
(P ¼ 0.039) and 16 weeks; 84.5  4.0% (P ¼ 0.012). (B) Swing phase. 96.3  6.4% vs 12 weeks; 117.0  7.8% (P ¼ 0.005) and 16 weeks; 125.8  7.1% (P ¼ 0.005). (C) Single stance phase.
99.9  6.9% vs 12 weeks; 80.0  9.3% (P ¼ 0.024) and 16 weeks; 81.6  4.5% (P ¼ 0.018). (D) Duty cycle. 99.7  5.6% vs 12 weeks; 84.7  6.3% (P ¼ 0.024) and 16 weeks; 82.1  3.4%
(P ¼ 0.007). (E) Swing speed. 96.0%  4.5% vs 12 weeks; 85.1  5.6% (P ¼ 0.029) and 16 weeks; 85.0  3.7% (P ¼ 0.029). * ¼ Time point which signiﬁcant differences were seen
compared with the baseline. The 800-HA group and 6000-HA group did not show changes in gait parameters longitudinally and maintained the same pattern as the sham group.
Signiﬁcant differences were found between the saline-treated group and the other groups in: (A) Stance phase. 12 weeks; saline: 85.6  6.4% (mean  95% conﬁdence interval) vs
sham: 101.4  4.6% (P ¼ 0.014), 800-HA: 104.1  7.0% (P ¼ 0.024) and 6000-HA: 106.1  9.3% (P ¼ 0.033), 16 weeks; saline: 84.5  4.0% vs sham: 99.0  7.5% (P ¼ 0.013), 800-HA:
106.5  7.0% (P ¼ 0.002) and 6000-HA: 102.4  7.0% (P ¼ 0.005). (B) Swing phase. 16 weeks; saline: 125.8  7.1% vs sham: 93.3  5.9% (P < 0.001), 800-HA: 91.3  8.0% (P ¼ 0.001)
and 6000-HA: 101.8  7.1% (P ¼ 0.004). (C) Single stance phase. 12 weeks; saline: 80.0  9.3% vs sham: 104.1%  10.6% (P ¼ 0.010), 800-HA: 99.7  6.0% (P ¼ 0.011) and 6000-HA:
105.7  9.2% (P ¼ 0.008), 16 weeks; saline: 81.6 4.5% vs sham: 103.1  9.0% (P ¼ 0.016), 800-HA: 109.2  8.6% (P ¼ 0.001) and 6000-HA: 104.3  9.5% (P ¼ 0.008). (D) Duty cycle. 12
weeks; saline: 84.7  6.3% vs sham: 101.8  6.8% (P ¼ 0.011), 800-HA: 98.2  5.2% (P ¼ 0.026) and 6000-HA: 102.4  6.5% (P ¼ 0.0149), 16 weeks; saline: 82.1  3.4% vs sham:
100.0  5.0% (P < 0.001), 800-HA: 105.5  7.0% (P ¼ 0.001) and 6000-HA: 102.8  8.8% (P ¼ 0.006). (E) Swing speed. 12 weeks; saline: 85.1  5.6% vs sham: 100.2  6.3% (P ¼ 0.048),
800-HA: 98.5  5.3% (P ¼ 0.025) and 6000-HA: 103.8  8.2% (P ¼ 0.012), 16 weeks; saline: 85.0  3.7% vs sham: 109.4  12.9% (P ¼ 0.005), 800-HA: 105.9  8.6% (P ¼ 0.012) and
6000-HA: 99.7  5.3% (P ¼ 0.011). # ¼ Time point which signiﬁcant differences were seen between saline group and the other groups.
Y. Muramatsu et al. / Osteoarthritis and Cartilage 22 (2014) 831e835 833at all three time points. At 8 weeks, loss of Safranin-O staining
was found in MFC and MTP. At 12 weeks, erosion and loss of
cartilage layers were seen, and at 16 weeks, vertical clefting and
erosions extending to the calciﬁed layer were found in broad
areas. Similar degenerative changes in the articular cartilage were
also seen in the 800-HA and 6000-HA groups (Fig. 2). There were
no apparent changes in subchondral bones and menisci in any of
the group.
The saline-treated, 800-HA and 6000-HA groups showed
signiﬁcantly higher scores than the sham group at each time point.
However, there were no signiﬁcant differences among the saline-
treated, 800-HA and 6000-HA groups. When comparing the
lateral compartment (LTP, LFC) and the medial compartment (MTP,
MFC), lateral compartment exhibited much slower progression of
cartilage degradation, and signiﬁcantly higher scores were seen in
the medial compartment in groups which underwent DMM sur-
gery (Table I). HA did not show any effects both on medial and
lateral cartilage at any time points.Discussion
Gait analysis on animal models
Biochemically-induced inﬂammatory models, such as mono-
iodo acetate injection into rodent knee joints8, have been tested
with CatWalk. These models produce rapidly progressive joint
damage, with behavioral changes occurring within a few days,
reﬂecting synovial inﬂammation.Surgical methods have also been used to induce cartilage
damage by destabilization of the knee joint, producing joint
degeneration more slowly than biochemically-induced models.
Gait disturbances have been described in using the anterior cruci-
ate ligament transection model in the rat and the medial menis-
cectomy model in mice9,10. These analyses showed changes in gait
far later than biochemically-induced models, mostly due to the
slow progression of OA, in accordance with the result of our study
using DMM model.
We detected changes in gait parameters at 12 and 16weeks after
the DMM. Only one study has reported gait analysis of the DMM
model using CatWalk where no changes in gait parameters were
reported up to 56 days11. Our study is the ﬁrst comprehensive study
to detect changes of gait parameters after DMM surgery. As OA
progressed in the saline-injected group, changes in gait pattern
appeared to reﬂect mice avoiding load on their affected limbs. The
same changes in gait patterns also have been seen in human OA12.
Our results showed that CatWalk could detect gait disturbance of
surgically induced OA models and suggested that assessment had
to be done up to the later phase of OA.Histological change and effect of IAI-HA
While gait parameters showed signiﬁcant differences at 12
weeks, histological changes were already evident at 8 weeks. Our
result that showed OA change most apparently in medial
compartment is compatible with previous studies. Although little is
known about how histological events affect locomotor behavior in
Fig. 2. Representative histological sections in the medial compartment obtained from each group at 8, 12 and 16 weeks. Safranin-O and Fast-Green staining (original
magniﬁcation 40, scale bars represent 200 mm).
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after destruction of the articular cartilage are evident in these mice.
We assessed the efﬁcacy of IAI-HA and showed that both of the
two molecular-weight HAs, with no difference between the two,
maintained a gait pattern similar to that of sham groups. IAI-HA
prevented the changes in gait patterns caused by progressive OA,
implying that IAI-HA decreased the pain and/or limited
dysfunction.
IAI-HA has been reported to be a symptom-modifying treatment
for knee OA2. Several studies have examined the way of pain
sensation in DMMmodel. They have indicated the up-regulation of
chemokine signals13 or the involvement of the opioid receptors in
the joint14. These could be possible explanations for the gait
changes observed in DMMmodels. However, as far as we know, no
related studies have evaluated the effect of IAI-HA against above-
mentioned mechanism in pain of OA.Table I
Histological score (OARSI score) compared between the medial and lateral
compartment
Histological score P-value
Total Lateral Medial vs sham Lateral vs medial
8 weeks
Sham 6.1  1.2 3.7  1.7 2.4  2.0 0.46
Saline 45.1  6.8 8.4  3.4 36.7  5.4 0.042 0.009
800-HA 49.1  6.2 15.2  10.8 33.9  8.5 0.042 0.047
6000-HA 45.2  6.2 10.3  4.9 35.5  11.4 0.042 0.009
12 weeks
Sham 11.7  4.0 6.9  3.2 4.6  2.4 0.25
Saline 57.0  7.9 13.8  3.8 43.2  8.7 0.043 0.009
800-HA 54.0  5.4 14.6  8.0 39.3  11.2 0.042 0.016
6000-HA 59.2  13.3 16.7  6.5 42.5  13.3 0.043 0.016
16 weeks
Sham 20.4  4.6 11.8  4.3 8.6  1.8 0.94
Saline 91.4  6.5 20.5  6.7 70.9  6.4 0.044 0.009
800-HA 81.0  5.5 21.2  5.9 59.8  7.7 0.045 0.009
6000-HA 79.8  12.3 16.2  5.0 63.6  11.0 0.045 0.009
Values are expressed as mean  95% conﬁdence intervals.In our study, histological examinations showed that IAI-HA
could not prevent articular destruction, even the slight destruc-
tion in the lateral compartment. However, a single IAI-HA injection
into the knee joint of mice with Transforming growth factor (TGF)-
b-induced OA showed that IAI-HA prevented ﬁbrosis of meniscus
and synovium that could cause contracture15. This might explain
maintained normal gait pattern observed in our study. Therefore,
limitation of our study would be that we have only assessed the
articular cartilage in histology.
Our explanations for changes in gait parameters remain spec-
ulative and further study is necessary to clarify whether pain or
contracture actually occurred in DMM model and how IAI-HA
affected.
Conclusion
In the DMM model, gait disturbances were detected by
CatWalk after histological changes occurred in the cartilage. IAI-
HA did not show chondroprotective effect in the DMM model.
CatWalk could be of use to objectively quantify gait disturbances
in the DMM model and could be a tool for assessing interventions
against OA in rodent models.
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